Sequential Administration of Oral 6-Thioguanine (6-TG) After Methotrexate (MTX) in Patients With Relapsed Hodgkin's Disease (Phase II)

This study has been completed.

Study NCT00587873 Information provided by Memorial Sloan-Kettering Cancer Center

First Received: December 26, 2007 Last Updated: June 10, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	June 2009
Primary Completion Date:	December 2003 (Final data collection date for primary outcome measure)